Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 04, 2021

SELL
$372.64 - $458.3 $80,117 - $98,534
-215 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$294.17 - $371.65 $1.4 Million - $1.77 Million
-4,761 Reduced 95.68%
215 $80,000
Q1 2021

May 10, 2021

SELL
$249.67 - $299.48 $670,363 - $804,103
-2,685 Reduced 35.05%
4,976 $1.44 Million
Q4 2020

Feb 16, 2021

SELL
$222.0 - $252.62 $642,246 - $730,829
-2,893 Reduced 27.41%
7,661 $1.91 Million
Q3 2020

Nov 13, 2020

SELL
$175.56 - $226.45 $532,824 - $687,275
-3,035 Reduced 22.33%
10,554 $2.39 Million
Q2 2020

Aug 10, 2020

SELL
$118.84 - $189.72 $16,875 - $26,940
-142 Reduced 1.03%
13,589 $2.37 Million
Q1 2020

May 11, 2020

SELL
$98.9 - $178.34 $20,571 - $37,094
-208 Reduced 1.49%
13,731 $1.73 Million
Q4 2019

Feb 13, 2020

SELL
$126.05 - $152.76 $37,562 - $45,522
-298 Reduced 2.09%
13,939 $2.13 Million
Q3 2019

Nov 12, 2019

SELL
$125.07 - $143.67 $15,508 - $17,815
-124 Reduced 0.86%
14,237 $1.89 Million
Q2 2019

Aug 12, 2019

SELL
$123.4 - $148.55 $40,475 - $48,724
-328 Reduced 2.23%
14,361 $2.04 Million
Q4 2018

Feb 13, 2019

SELL
$105.09 - $137.23 $126,108 - $164,676
-1,200 Reduced 7.55%
14,689 $1.66 Million
Q3 2018

Nov 13, 2018

SELL
$112.11 - $134.54 $569,630 - $683,597
-5,081 Reduced 24.23%
15,889 $2.14 Million
Q2 2018

Aug 10, 2018

SELL
$102.37 - $117.25 $115,166 - $131,906
-1,125 Reduced 5.09%
20,970 $2.35 Million
Q4 2017

Feb 09, 2018

SELL
$100.43 - $118.09 $579,882 - $681,851
-5,774 Reduced 20.72%
22,095 $2.42 Million
Q3 2017

Oct 20, 2017

SELL
$96.72 - $109.26 $1 Million - $1.13 Million
-10,378 Reduced 27.13%
27,869 $3.01 Million
Q3 2017

Oct 18, 2017

BUY
$96.72 - $109.26 $3.7 Million - $4.18 Million
38,247
38,247 $2.29 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.